INSPE

InSpe Bio is a French biotechnology company developing a proprietary platform for In-cell Protein Synthesis (ICPS). Spun out from the Institut Curie, the company's technology enables the production of complex and "difficult-to-express" proteins by leveraging the internal machinery of cells. This platform has broad applications in biomanufacturing, research tools, and potentially as a therapeutic delivery system for protein-based medicines. InSpe Bio aims to revolutionize how therapeutic proteins are produced and delivered, particularly for targets that are currently inaccessible via standard recombinant methods. The company is currently focused on scaling its platform and establishing partnerships within the pharmaceutical industry.